Compile Data Set for Download or QSAR
Report error Found 39 Enz. Inhib. hit(s) with all data for entry = 50020400
TargetReceptor-type tyrosine-protein kinase FLT3(Human)
Henan University of Chinese Medicine

Curated by ChEMBL
LigandPNGBDBM50629602(CHEMBL5401158)
Affinity DataKd:  121nMAssay Description:Binding affinity to autoinhibited FLT3 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/19/2024
Entry Details
PubMed
TargetReceptor-type tyrosine-protein kinase FLT3(Human)
Henan University of Chinese Medicine

Curated by ChEMBL
LigandPNGBDBM50629602(CHEMBL5401158)
Affinity DataKd:  67nMAssay Description:Binding affinity to FLT3 R834Q mutant (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/19/2024
Entry Details
PubMed
TargetReceptor-type tyrosine-protein kinase FLT3(Human)
Henan University of Chinese Medicine

Curated by ChEMBL
LigandPNGBDBM50629602(CHEMBL5401158)
Affinity DataKd:  77nMAssay Description:Binding affinity to FLT3 N841I mutant (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/19/2024
Entry Details
PubMed
TargetReceptor-type tyrosine-protein kinase FLT3(Human)
Henan University of Chinese Medicine

Curated by ChEMBL
LigandPNGBDBM50629602(CHEMBL5401158)
Affinity DataKd:  121nMAssay Description:Binding affinity to FLT3 K663Q mutant (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/19/2024
Entry Details
PubMed
TargetReceptor-type tyrosine-protein kinase FLT3(Human)
Henan University of Chinese Medicine

Curated by ChEMBL
LigandPNGBDBM50629602(CHEMBL5401158)
Affinity DataKd:  1.60nMAssay Description:Binding affinity to FLT3 ITD/F691L mutant (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/19/2024
Entry Details
PubMed
TargetReceptor-type tyrosine-protein kinase FLT3(Human)
Henan University of Chinese Medicine

Curated by ChEMBL
LigandPNGBDBM50629602(CHEMBL5401158)
Affinity DataKd:  0.580nMAssay Description:Binding affinity to FLT3 ITD/D835V mutant (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/19/2024
Entry Details
PubMed
TargetReceptor-type tyrosine-protein kinase FLT3(Human)
Henan University of Chinese Medicine

Curated by ChEMBL
LigandPNGBDBM50629602(CHEMBL5401158)
Affinity DataKd:  18nMAssay Description:Binding affinity to FLT3 ITD mutant (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/19/2024
Entry Details
PubMed
TargetReceptor-type tyrosine-protein kinase FLT3(Human)
Henan University of Chinese Medicine

Curated by ChEMBL
LigandPNGBDBM50629602(CHEMBL5401158)
Affinity DataKd:  7.20nMAssay Description:Binding affinity to FLT3 D835Y mutant (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/19/2024
Entry Details
PubMed
TargetReceptor-type tyrosine-protein kinase FLT3(Human)
Henan University of Chinese Medicine

Curated by ChEMBL
LigandPNGBDBM50629602(CHEMBL5401158)
Affinity DataKd:  1.5nMAssay Description:Binding affinity to FLT3 D835V mutant (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/19/2024
Entry Details
PubMed
TargetReceptor-type tyrosine-protein kinase FLT3(Human)
Henan University of Chinese Medicine

Curated by ChEMBL
LigandPNGBDBM50629602(CHEMBL5401158)
Affinity DataKd:  22nMAssay Description:Binding affinity to FLT3 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/19/2024
Entry Details
PubMed
TargetReceptor-type tyrosine-protein kinase FLT3(Human)
Henan University of Chinese Medicine

Curated by ChEMBL
LigandPNGBDBM50629602(CHEMBL5401158)
Affinity DataKd:  49nMAssay Description:Binding affinity to FLT3 D835H mutant (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/19/2024
Entry Details
PubMed
TargetReceptor-type tyrosine-protein kinase FLT3(Human)
Henan University of Chinese Medicine

Curated by ChEMBL
LigandPNGBDBM50270304(CHEMBL4077071)
Affinity DataIC50: 0.270nMAssay Description:Inhibition of human FLT3 using EAIYAAPFAKKK and [gamma-33P]-ATP as substrate pretreated for 20 mins followed by [gamma-33P]-ATP addition and measured...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/19/2024
Entry Details
PubMed
TargetReceptor-type tyrosine-protein kinase FLT3(Human)
Henan University of Chinese Medicine

Curated by ChEMBL
LigandPNGBDBM50629602(CHEMBL5401158)
Affinity DataIC50: 0.620nMAssay Description:Inhibition of human FLT3 using EAIYAAPFAKKK and [gamma-33P]-ATP as substrate pretreated for 20 mins followed by [gamma-33P]-ATP addition and measured...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/19/2024
Entry Details
PubMed
TargetCyclin-dependent kinase 6(Human)
Henan University of Chinese Medicine

Curated by ChEMBL
LigandPNGBDBM50270304(CHEMBL4077071)
Affinity DataIC50: 2nMAssay Description:Inhibition of human CDK6 pretreated for 20 mins followed by [gamma-33P]-ATP addition and measured after 120 mins in presence of 10 uM ATP by radiomet...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/19/2024
Entry Details
PubMed
TargetCyclin-dependent kinase 2(Human)
Henan University of Chinese Medicine

Curated by ChEMBL
LigandPNGBDBM50270304(CHEMBL4077071)
Affinity DataIC50: 2.5nMAssay Description:Inhibition of human CDK2 pretreated for 20 mins followed by [gamma-33P]-ATP addition and measured after 120 mins in presence of 10 uM ATP by radiomet...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/19/2024
Entry Details
PubMed
TargetReceptor-type tyrosine-protein kinase FLT3(Human)
Henan University of Chinese Medicine

Curated by ChEMBL
LigandPNGBDBM50629587(CHEMBL5399420)
Affinity DataIC50: 7.30nMAssay Description:Inhibition of human FLT3 using EAIYAAPFAKKK and [gamma-33P]-ATP as substrate pretreated for 20 mins followed by [gamma-33P]-ATP addition and measured...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/19/2024
Entry Details
PubMed
TargetReceptor-type tyrosine-protein kinase FLT3(Human)
Henan University of Chinese Medicine

Curated by ChEMBL
LigandPNGBDBM50629597(CHEMBL5435746)
Affinity DataIC50: 7.80nMAssay Description:Inhibition of human FLT3 using EAIYAAPFAKKK and [gamma-33P]-ATP as substrate pretreated for 20 mins followed by [gamma-33P]-ATP addition and measured...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/19/2024
Entry Details
PubMed
TargetReceptor-type tyrosine-protein kinase FLT3(Human)
Henan University of Chinese Medicine

Curated by ChEMBL
LigandPNGBDBM50629592(CHEMBL5415967)
Affinity DataIC50: 8.40nMAssay Description:Inhibition of human FLT3 using EAIYAAPFAKKK and [gamma-33P]-ATP as substrate pretreated for 20 mins followed by [gamma-33P]-ATP addition and measured...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/19/2024
Entry Details
PubMed
TargetReceptor-type tyrosine-protein kinase FLT3(Human)
Henan University of Chinese Medicine

Curated by ChEMBL
LigandPNGBDBM50629603(CHEMBL5432406)
Affinity DataIC50: 11nMAssay Description:Inhibition of human FLT3 using EAIYAAPFAKKK and [gamma-33P]-ATP as substrate pretreated for 20 mins followed by [gamma-33P]-ATP addition and measured...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/19/2024
Entry Details
PubMed
TargetReceptor-type tyrosine-protein kinase FLT3(Human)
Henan University of Chinese Medicine

Curated by ChEMBL
LigandPNGBDBM50629599(CHEMBL5394265)
Affinity DataIC50: 11nMAssay Description:Inhibition of human FLT3 using EAIYAAPFAKKK and [gamma-33P]-ATP as substrate pretreated for 20 mins followed by [gamma-33P]-ATP addition and measured...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/19/2024
Entry Details
PubMed
TargetCyclin-dependent kinase 6(Human)
Henan University of Chinese Medicine

Curated by ChEMBL
LigandPNGBDBM50629587(CHEMBL5399420)
Affinity DataIC50: 14nMAssay Description:Inhibition of human CDK6 pretreated for 20 mins followed by [gamma-33P]-ATP addition and measured after 120 mins in presence of 10 uM ATP by radiomet...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/19/2024
Entry Details
PubMed
TargetReceptor-type tyrosine-protein kinase FLT3(Human)
Henan University of Chinese Medicine

Curated by ChEMBL
LigandPNGBDBM50629591(CHEMBL5401759)
Affinity DataIC50: 15nMAssay Description:Inhibition of human FLT3 using EAIYAAPFAKKK and [gamma-33P]-ATP as substrate pretreated for 20 mins followed by [gamma-33P]-ATP addition and measured...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/19/2024
Entry Details
PubMed
TargetReceptor-type tyrosine-protein kinase FLT3(Human)
Henan University of Chinese Medicine

Curated by ChEMBL
LigandPNGBDBM50629588(CHEMBL5422209)
Affinity DataIC50: 19nMAssay Description:Inhibition of human FLT3 using EAIYAAPFAKKK and [gamma-33P]-ATP as substrate pretreated for 20 mins followed by [gamma-33P]-ATP addition and measured...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/19/2024
Entry Details
PubMed
TargetReceptor-type tyrosine-protein kinase FLT3(Human)
Henan University of Chinese Medicine

Curated by ChEMBL
LigandPNGBDBM50629600(CHEMBL5393736)
Affinity DataIC50: 19nMAssay Description:Inhibition of human FLT3 using EAIYAAPFAKKK and [gamma-33P]-ATP as substrate pretreated for 20 mins followed by [gamma-33P]-ATP addition and measured...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/19/2024
Entry Details
PubMed
TargetReceptor-type tyrosine-protein kinase FLT3(Human)
Henan University of Chinese Medicine

Curated by ChEMBL
LigandPNGBDBM50629598(CHEMBL5429593)
Affinity DataIC50: 21nMAssay Description:Inhibition of human FLT3 using EAIYAAPFAKKK and [gamma-33P]-ATP as substrate pretreated for 20 mins followed by [gamma-33P]-ATP addition and measured...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/19/2024
Entry Details
PubMed
TargetCyclin-dependent kinase 2(Human)
Henan University of Chinese Medicine

Curated by ChEMBL
LigandPNGBDBM50629587(CHEMBL5399420)
Affinity DataIC50: 23nMAssay Description:Inhibition of human CDK2 pretreated for 20 mins followed by [gamma-33P]-ATP addition and measured after 120 mins in presence of 10 uM ATP by radiomet...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/19/2024
Entry Details
PubMed
TargetReceptor-type tyrosine-protein kinase FLT3(Human)
Henan University of Chinese Medicine

Curated by ChEMBL
LigandPNGBDBM50629593(CHEMBL5437521)
Affinity DataIC50: 25nMAssay Description:Inhibition of human FLT3 using EAIYAAPFAKKK and [gamma-33P]-ATP as substrate pretreated for 20 mins followed by [gamma-33P]-ATP addition and measured...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/19/2024
Entry Details
PubMed
TargetReceptor-type tyrosine-protein kinase FLT3(Human)
Henan University of Chinese Medicine

Curated by ChEMBL
LigandPNGBDBM50629594(CHEMBL5433856)
Affinity DataIC50: 29nMAssay Description:Inhibition of human FLT3 using EAIYAAPFAKKK and [gamma-33P]-ATP as substrate pretreated for 20 mins followed by [gamma-33P]-ATP addition and measured...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/19/2024
Entry Details
PubMed
TargetReceptor-type tyrosine-protein kinase FLT3(Human)
Henan University of Chinese Medicine

Curated by ChEMBL
LigandPNGBDBM50629601(CHEMBL5395823)
Affinity DataIC50: 29nMAssay Description:Inhibition of human FLT3 using EAIYAAPFAKKK and [gamma-33P]-ATP as substrate pretreated for 20 mins followed by [gamma-33P]-ATP addition and measured...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/19/2024
Entry Details
PubMed
TargetReceptor-type tyrosine-protein kinase FLT3(Human)
Henan University of Chinese Medicine

Curated by ChEMBL
LigandPNGBDBM50629589(CHEMBL5417167)
Affinity DataIC50: 30nMAssay Description:Inhibition of human FLT3 using EAIYAAPFAKKK and [gamma-33P]-ATP as substrate pretreated for 20 mins followed by [gamma-33P]-ATP addition and measured...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/19/2024
Entry Details
PubMed
TargetReceptor-type tyrosine-protein kinase FLT3(Human)
Henan University of Chinese Medicine

Curated by ChEMBL
LigandPNGBDBM50629596(CHEMBL5439508)
Affinity DataIC50: 41nMAssay Description:Inhibition of human FLT3 using EAIYAAPFAKKK and [gamma-33P]-ATP as substrate pretreated for 20 mins followed by [gamma-33P]-ATP addition and measured...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/19/2024
Entry Details
PubMed
TargetReceptor-type tyrosine-protein kinase FLT3(Human)
Henan University of Chinese Medicine

Curated by ChEMBL
LigandPNGBDBM50629595(CHEMBL5397621)
Affinity DataIC50: 45nMAssay Description:Inhibition of human FLT3 using EAIYAAPFAKKK and [gamma-33P]-ATP as substrate pretreated for 20 mins followed by [gamma-33P]-ATP addition and measured...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/19/2024
Entry Details
PubMed
TargetReceptor-type tyrosine-protein kinase FLT3(Human)
Henan University of Chinese Medicine

Curated by ChEMBL
LigandPNGBDBM50629590(CHEMBL5418880)
Affinity DataIC50: 58nMAssay Description:Inhibition of human FLT3 using EAIYAAPFAKKK and [gamma-33P]-ATP as substrate pretreated for 20 mins followed by [gamma-33P]-ATP addition and measured...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/19/2024
Entry Details
PubMed
TargetCyclin-dependent kinase 2(Human)
Henan University of Chinese Medicine

Curated by ChEMBL
LigandPNGBDBM50629602(CHEMBL5401158)
Affinity DataIC50: 98nMAssay Description:Inhibition of human CDK2 pretreated for 20 mins followed by [gamma-33P]-ATP addition and measured after 120 mins in presence of 10 uM ATP by radiomet...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/19/2024
Entry Details
PubMed
TargetCyclin-dependent kinase 6(Human)
Henan University of Chinese Medicine

Curated by ChEMBL
LigandPNGBDBM50629602(CHEMBL5401158)
Affinity DataIC50: 122nMAssay Description:Inhibition of human CDK6 pretreated for 20 mins followed by [gamma-33P]-ATP addition and measured after 120 mins in presence of 10 uM ATP by radiomet...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/19/2024
Entry Details
PubMed
TargetCyclin-dependent kinase 6(Human)
Henan University of Chinese Medicine

Curated by ChEMBL
LigandPNGBDBM50629592(CHEMBL5415967)
Affinity DataIC50: 125nMAssay Description:Inhibition of human CDK6 pretreated for 20 mins followed by [gamma-33P]-ATP addition and measured after 120 mins in presence of 10 uM ATP by radiomet...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/19/2024
Entry Details
PubMed
TargetCyclin-dependent kinase 2(Human)
Henan University of Chinese Medicine

Curated by ChEMBL
LigandPNGBDBM50629597(CHEMBL5435746)
Affinity DataIC50: 135nMAssay Description:Inhibition of human CDK2 pretreated for 20 mins followed by [gamma-33P]-ATP addition and measured after 120 mins in presence of 10 uM ATP by radiomet...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/19/2024
Entry Details
PubMed
TargetCyclin-dependent kinase 6(Human)
Henan University of Chinese Medicine

Curated by ChEMBL
LigandPNGBDBM50629597(CHEMBL5435746)
Affinity DataIC50: 158nMAssay Description:Inhibition of human CDK6 pretreated for 20 mins followed by [gamma-33P]-ATP addition and measured after 120 mins in presence of 10 uM ATP by radiomet...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/19/2024
Entry Details
PubMed
TargetCyclin-dependent kinase 2(Human)
Henan University of Chinese Medicine

Curated by ChEMBL
LigandPNGBDBM50629592(CHEMBL5415967)
Affinity DataIC50: 193nMAssay Description:Inhibition of human CDK2 pretreated for 20 mins followed by [gamma-33P]-ATP addition and measured after 120 mins in presence of 10 uM ATP by radiomet...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/19/2024
Entry Details
PubMed